Court Overturns Insulet Verdict
A US appeals court reversed a 452 million dollar trade secret verdict that Insulet won against EOFlow. The court found that Insulet waited too long to file its lawsuit regarding insulin-pump technology.
Xurve View
Insights:
Xurve View
A United States appeals court overturned a $452M trade secret verdict that INSULET CORP won against rival EOFLOW CO LTD on Thursday afternoon. The decision reverses a 2024 Massachusetts federal jury award over insulin-pump technology. The ruling removes a major financial penalty for the South Korea-based medical device maker.
